Trial Profile
A thorough QTc study of olmesartan medoxomil in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 11 Nov 2015 New trial record